Roseanne Gerding

Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity

Stanley D. Chamberlain, Anikó M. Redman, Joseph W. Wilson et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 57 citations · Full text

Medicinal Chemistry, Biochemistry, Natural Sciences +8

Discovery and optimization of imidazo[1,2-a]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R)

Kyle A. Emmitte, Brian J. Wilson, Erich W. Baum et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 32 citations · Full text

Medicinal Chemistry, Biochemistry, Natural Sciences +7

Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase

Stanley D. Chamberlain, Joseph W. Wilson, Felix Deanda et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 30 citations · Full text

Biochemistry, Medicine, Natural Sciences +8

Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase

Samarjit Patnaik, Kirk L. Stevens, Roseanne Gerding et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 26 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +7

Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors

Kirk L. Stevens, Krystal J. Alligood, Jennifer G. Badiang Alberti et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 20 citations · Full text

Medicinal Chemistry, Biochemistry, Stereochemical Effects +10